One university graduate said America "is losing scientific talent because of this broad, systematic attack on science funding ...

The county Board of Supervisors unanimously approved nearly $30 million, via the state Proposition 1 program, for an adult ...

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO, June 04, 2025--Biocom California, the association representing the California life science industry, today announced the appointment of Thierry ...

What do Día de las Madres (Mexican Mother’s Day) and the 75 th anniversary of the National Science Foundation (NSF) have in ...

The MLSys Group and the Hao AI Lab, led by Hao Zhang, an assistant professor at the Halıcıoğlu Data Science Institute (HDSI) ...

Swiss pharmaceutical giant Novartis is poised to expand its profile in the San Diego area, announcing plans to acquire Regulus Therapeutics, a local company on the cusp of bringing a potential ...

Novartis has made kidney disorders an area ... to pay $800 million up front to buy Regulus. Shareholders of the San Diego-based biotech could get more if its lead asset, a genetic medicine called ...

Novartis has agreed to acquire Regulus Therapeutics ... Shares of Regulus, a San Diego biopharmaceutical company specializing in medicines targeting microRNAs, rocketed 135% to $7.90 in premarket ...

2025 - Novartis today announced that it has entered into an agreement to acquire Regulus Therapeutics, a San Diego-based, publicly traded (Nasdaq: RGLS) clinical-stage biopharmaceutical company ...

Swiss pharmaceutical firm Novartis on Tuesday reported better-than-expected first-quarter sales and raised its full-year guidance. Stream San Diego News for free, 24/7, wherever you are with NBC 7.

Further reinforcing its innovation pipeline, Novartis will also launch a $1.1 billion biomedical research and innovation hub in San Diego, California, slated to open between 2028 and 2029.